Christine Marie Plummer sold $7,175 of STEX
Chief Financial Officer at BioSig Technologies, Inc.. 13,344 shares at an average of $0.54, traded Oct 1, 2026, filed Oct 7, 2026.
Score components
- +22RoleCFO
- 0Trade size$7k at market
- 0Share of holdings soldSold 2.8% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-046199, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 1, 2026 | FTax withholding Common stock | -11,508 | $0.71 | $8,170 | 474,989 | 5 d ago |
| Oct 1, 2026 | SOpen-market sale Common Stock | -13,344 | $0.54 | $7,175 | 461,645 | 5 d ago |
Related signals
Other insiders at BioSig Technologies, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 29Weak | BioSig Technologies, Inc. | Mitchell Young Williams Chief Investment Officer | $35k 65,538 shares | -2% | |
| 22Weak | STEXsell BioSig Technologies, Inc. | Mitchell Young Williams Chief Investment Officer | $52k 72,689 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.